UBS reaffirmed their neutral rating on shares of Commerzbank (ETR:CBK) in a research report report published on Monday, www.boersen-zeitung.de reports.

A number of other analysts have also recently commented on the stock. Royal Bank of Canada set a €9.00 ($10.71) price target on shares of Commerzbank and gave the company a neutral rating in a research note on Friday, December 8th. Goldman Sachs Group set a €10.50 ($12.50) price target on shares of Commerzbank and gave the company a neutral rating in a research note on Wednesday, December 6th. Citigroup reissued a buy rating on shares of Commerzbank in a research report on Tuesday, November 21st. Morgan Stanley set a €11.15 ($13.27) price objective on shares of Commerzbank and gave the company a neutral rating in a research report on Wednesday, November 15th. Finally, S&P Global set a €10.00 ($11.90) price objective on shares of Commerzbank and gave the company a sell rating in a research report on Friday, November 10th. Five investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and one has issued a buy rating to the stock. Commerzbank has a consensus rating of Hold and a consensus price target of €10.22 ($12.17).

Commerzbank (ETR CBK) opened at €12.76 ($15.18) on Monday. Commerzbank has a 1-year low of €6.97 ($8.30) and a 1-year high of €12.84 ($15.29).

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.watchlistnews.com/ubs-reaffirms-neutral-rating-for-commerzbank-cbk/1762519.html.

Commerzbank Company Profile

Analyst Recommendations for Commerzbank (ETR:CBK)

Receive News & Ratings for Commerzbank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Commerzbank and related companies with MarketBeat.com's FREE daily email newsletter.